查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球癲癇監測設備市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1346824

全球癲癇監測設備市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Epilepsy Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

全球癲癇監測設備市場需求預計將從 2022 年的 584.22 萬美元達到 2030 年近 889.81 萬美元的市場規模，2023-2030 年研究期間年複合成長率為 5.4%。

癲癇監測設備是旨在監測和記錄癲癇患者大腦活動的醫療設備。癲癇是一種以反復發作為特徵的神經系統疾病，涉及大腦內突然且無法控制的電活動激增。監測設備通過記錄和分析腦電波模式（也稱為腦電圖 (EEG)），在診斷、管理和了解癲癇症方面發揮著至關重要的作用。

市場動態：

癲癇及相關疾病的患病率不斷上升，人們的認知不斷提高，診斷率不斷提高，推動了對有效監測解決方案的需求。先進的腦電圖感測器和無線通訊等技術進步帶來了更先進和方便用戶使用的監測設備。個性化的治療方法和長期監測的能力增加了對準確和全面的數據收集的需求。攜帶式和家庭監測選項（包括穿戴式設備）已經普及，使患者能夠在日常環境中受到監測。遠程醫療和遠程醫療保健解決方案的興起也擴大了遠程監控患者的可能性。政府舉措、基礎設施發展以及患者和護理人員對非侵入性解決方案日益成長的偏好都促進了市場的成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球癲癇監測設備市場的每個細分市場進行了包容性評估。癲癇監測設備行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲癲癇監測設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。癲癇監測設備市場的主要參與者包括 Natus Medical, Inc（美國）、Compumedics Limited（澳大利亞）、Empatica, Inc.（美國）、The Magstim Co. Ltd.（英國）、Nihon Kohden Corporation（日本）、Medtronic Plc （愛爾蘭）、Masimo Corporation（美國）、Boston Scientific Corporation（美國）、Dragerwerk AG & Co. KGaA（德國）、mjn Neuroserveis SL（西班牙）、Abbott Laboratories, Inc.（美國）、LivAssured BV（荷蘭）、 BioSerenity （法國）、Aleva Neurotherapeutics（瑞士）、Medpage, Ltd.（英國）、Neurosoft（俄羅斯）、Advanced Brain Monitoring（美國）、Lifelines Neuro Company, LLC（美國）、Mitsar Co., Ltd（俄羅斯）。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：癲癇監測設備 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：全球癲癇監測設備市場分析：按產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 穿戴式設備
  • 常規設備（深部腦刺激設備、監測設備、EMG 設備、MEG 設備、其他監測設備）

第 6 章：全球癲癇監測設備市場分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院
  • 門診手術中心和診所
  • 神經病學中心
  • 診斷中心
  • 家庭護理設置

第 7 章：全球癲癇監測設備市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：癲癇監測設備公司的競爭格局

  • 癲癇監測設備市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市場佔有率分析
  • 市場集中度
  • Natus Medical Inc (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Compumedics Limited (Australia)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Empatica Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • The Magstim Co. Ltd. (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Nihon Kohden Corporation (Japan)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medtronic Plc (Ireland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Masimo Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boston Scientific Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dragerwerk AG & Co. KGaA (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • mjn Neuroserveis SL (Spain)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abbott Laboratories Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • LivAssured BV (Netherlands)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BioSerenity (France)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Aleva Neurotherapeutics (Switzerland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medpage Ltd. (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Neurosoft (Russia)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Advanced Brain Monitoring (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lifelines Neuro Company LLC (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mitsar Co. Ltd (Russia)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR112112055

The global demand for Epilepsy Monitoring Devices Market is presumed to reach the market size of nearly USD 889.81 MN by 2030 from USD 584.22 MN in 2022 with a CAGR of 5.4% under the study period 2023 - 2030.

Epilepsy monitoring devices are medical devices designed to monitor and record the brain activity of individuals with epilepsy. Epilepsy is a neurological condition marked by repetitive seizures, which involve abrupt and uncontrollable surges of electrical activity within the brain. Monitoring devices play a crucial role in diagnosing, managing, and understanding epilepsy by recording and analyzing brain wave patterns, also known as electroencephalograms (EEG).

MARKET DYNAMICS:

The increasing prevalence of epilepsy and related conditions, along with greater awareness and improved diagnosis rates, has driven the demand for effective monitoring solutions. Technological advancements, such as sophisticated EEG sensors and wireless communication, have led to more advanced and user-friendly monitoring devices. Personalized treatment approaches and the capability for long-term monitoring have increased the need for accurate and comprehensive data collection. Portable and home-based monitoring options, including wearable devices, have gained popularity, allowing patients to be monitored in their daily environments. The rise of telemedicine and remote healthcare solutions has also expanded the possibilities for monitoring patients remotely. Government initiatives, infrastructure development, and growing patient and caregiver preferences for non-invasive solutions have contributed to the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of epilepsy monitoring devices. The growth and trends of epilepsy monitoring devices industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the epilepsy monitoring devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Wearable Devices
  • Conventional Devices (Deep Brain Stimulation Devices, Montioring Devices, Emg Devices, Meg Devices, Other Monitoring Devices)

By End User

  • Hospitals
  • Ambulatory Surgery Centers & Clinics
  • Neurology Centres
  • Diagnostic Centres
  • Home Care Settings

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Epilepsy Monitoring Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Epilepsy Monitoring Devices market include Natus Medical, Inc (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Dragerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd (Russia). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . EPILEPSY MONITORING DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EPILEPSY MONITORING DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Wearable Devices Historic and Forecast Sales by Regions
  • 5.5 Conventional Devices (Deep Brain Stimulation Devices, Montioring Devices, EMG Devices, MEG Devices, Other Monitoring Devices) Historic and Forecast Sales by Regions

6 . GLOBAL EPILEPSY MONITORING DEVICES MARKET ANALYSIS BY END USER

  • 6.1 Overview by End User
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End User
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Ambulatory Surgery Centers & Clinics Historic and Forecast Sales by Regions
  • 6.6 Neurology Centres Historic and Forecast Sales by Regions
  • 6.7 Diagnostic Centres Historic and Forecast Sales by Regions
  • 6.8 Home Care Settings Historic and Forecast Sales by Regions

7 . GLOBAL EPILEPSY MONITORING DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE EPILEPSY MONITORING DEVICES COMPANIES

  • 8.1. Epilepsy Monitoring Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF EPILEPSY MONITORING DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Natus Medical Inc (US)
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Compumedics Limited (Australia)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Empatica Inc. (US)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. The Magstim Co. Ltd. (UK)
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Nihon Kohden Corporation (Japan)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Medtronic Plc (Ireland)
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Masimo Corporation (US)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Boston Scientific Corporation (US)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Dragerwerk AG & Co. KGaA (Germany)
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. mjn Neuroserveis S.L. (Spain)
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Abbott Laboratories Inc. (US)
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. LivAssured B.V. (Netherlands)
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. BioSerenity (France)
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Aleva Neurotherapeutics (Switzerland)
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Medpage Ltd. (UK)
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Neurosoft (Russia)
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. Advanced Brain Monitoring (US)
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments
  • 9.20. Lifelines Neuro Company LLC (US)
    • 9.20.1. Company Overview
    • 9.20.2. Company Revenue
    • 9.20.3. Products
    • 9.20.4. Recent Developments
  • 9.21. Mitsar Co. Ltd (Russia)
    • 9.21.1. Company Overview
    • 9.21.2. Company Revenue
    • 9.21.3. Products
    • 9.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Wearable Devices Market Sales by Geography (USD MN)
  • Conventional Devices (Deep Brain Stimulation Devices, Montioring Devices, EMG Devices, MEG Devices, Other Monitoring Devices) Market Sales by Geography (USD MN)
  • Analysis Market by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgery Centers & Clinics Market Sales by Geography (USD MN)
  • Neurology Centres Market Sales by Geography (USD MN)
  • Diagnostic Centres Market Sales by Geography (USD MN)
  • Home Care Settings Market Sales by Geography (USD MN)
  • Global Epilepsy Monitoring Devices Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Epilepsy Monitoring Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Epilepsy Monitoring Devices Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Wearable Devices Market Sales by Geography (USD MN)
  • Conventional Devices (Deep Brain Stimulation Devices, Montioring Devices, EMG Devices, MEG Devices, Other Monitoring Devices) Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgery Centers & Clinics Market Sales by Geography (USD MN)
  • Neurology Centres Market Sales by Geography (USD MN)
  • Diagnostic Centres Market Sales by Geography (USD MN)
  • Home Care Settings Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.